Dow Up 0.12% Nasdaq Up 1.35%

Celgene Corporation (CELG)

-NasdaqGS
92.00 Up 3.88(4.40%) 4:00PM EDT
|After Hours : 92.00 0.00 (0.00%) 4:51PM EDT - Nasdaq Real Time Price
Prev Close:88.12
Open:88.84
Bid:91.28 x 100
Ask:92.39 x 200
1y Target Est:104.39
Beta:1.5
Next Earnings Date:23-Oct-14CELG Earnings announcement
Day's Range:88.57 - 92.55
52wk Range:66.85 - 96.50
Volume:7,959,439
Avg Vol (3m):4,363,050
Market Cap:73.55B
P/E (ttm):53.18
EPS (ttm):1.73
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
CELGUp 4.40%73.55B
JNJUp 0.51%279.77B

Key Statistics

Forward P/E (1 yr):18.85
P/S (ttm):10.02
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :3.67
Quarterly EPS Est (Sep-14) :0.95
Mean Recommendation*:1.8
PEG Ratio (5 yr expected):0.91

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Celgene Corporation, a biopharmaceutical company, discovers, develops, and commercializes therapies to treat cancer and immune-inflammatory related diseases in the United States and internationally. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback